[go: up one dir, main page]

ES356551A1 - A procedure for the preparation of pharmaceutical compositions of prolonged action in doses administrables in oral form. (Machine-translation by Google Translate, not legally binding) - Google Patents

A procedure for the preparation of pharmaceutical compositions of prolonged action in doses administrables in oral form. (Machine-translation by Google Translate, not legally binding)

Info

Publication number
ES356551A1
ES356551A1 ES356551A ES356551A ES356551A1 ES 356551 A1 ES356551 A1 ES 356551A1 ES 356551 A ES356551 A ES 356551A ES 356551 A ES356551 A ES 356551A ES 356551 A1 ES356551 A1 ES 356551A1
Authority
ES
Spain
Prior art keywords
translation
preparation
machine
pharmaceutical compositions
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES356551A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
COTTY
Original Assignee
COTTY
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by COTTY filed Critical COTTY
Publication of ES356551A1 publication Critical patent/ES356551A1/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A process for the preparation of long-acting pharmaceutical compositions in orally administrable doses consisting of mixing a first drug (a) and a drug glucuronide (b), said drug glucuronide having been selected from the group consisting of a glucuronide of said first drug and drugs that exercise my analogous pharmacological action; the total amount of active drug contained in said composition being found at a therapeutically active level. (Machine-translation by Google Translate, not legally binding)
ES356551A 1967-08-01 1968-07-26 A procedure for the preparation of pharmaceutical compositions of prolonged action in doses administrables in oral form. (Machine-translation by Google Translate, not legally binding) Expired ES356551A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US65749667A 1967-08-01 1967-08-01

Publications (1)

Publication Number Publication Date
ES356551A1 true ES356551A1 (en) 1970-02-01

Family

ID=24637422

Family Applications (1)

Application Number Title Priority Date Filing Date
ES356551A Expired ES356551A1 (en) 1967-08-01 1968-07-26 A procedure for the preparation of pharmaceutical compositions of prolonged action in doses administrables in oral form. (Machine-translation by Google Translate, not legally binding)

Country Status (4)

Country Link
BE (1) BE718710A (en)
ES (1) ES356551A1 (en)
FR (1) FR7749M (en)
NL (1) NL6810371A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3832277A1 (en) * 1988-09-22 1990-03-29 Guenter Stephan effervescent tablet

Also Published As

Publication number Publication date
NL6810371A (en) 1969-02-04
BE718710A (en) 1969-01-27
FR7749M (en) 1970-03-16

Similar Documents

Publication Publication Date Title
BE575313A (en) A drug composition for oral administration comprising a porous mass and a solid drug
ES303909A1 (en) A procedure for coating a pharmaceutical composition. (Machine-translation by Google Translate, not legally binding)
SE7416039L (en)
PH13841A (en) Pharmaceutical preparation adapted for oral administration
JPS5241214A (en) Method of making preparations for oral administration
ZA764868B (en) Novel pharmaceutical preparation adapted for oral administration
IL51096A0 (en) Novel pharmaceutical dosage form
IL30001A0 (en) Phenoxyalkanolamines,processes for their preparation and pharmaceutical compositions containing them
DK123141B (en) Process for stabilizing a pharmaceutical composition suitable for oral administration, containing a basic dihydrodibenzazepine.
JPS52108028A (en) Remedies for dysacousis
ES356551A1 (en) A procedure for the preparation of pharmaceutical compositions of prolonged action in doses administrables in oral form. (Machine-translation by Google Translate, not legally binding)
IL30594A0 (en) New pharmaceutical steroidal compositions,especially useful for treatment of climacteric disorders
ES449797A1 (en) 1,3,8-triazaspiro(4.5)decan-4-one derivatives
ES294897A1 (en) Improvements introduced in the preparation of pharmaceutical compositions in the form of unit dose (Machine-translation by Google Translate, not legally binding)
GB1049996A (en) New medicine with anti-inflammatory and anti-rheumatic activity
ES283585A1 (en) A procedure for the preparation of a therapeutic composition (Machine-translation by Google Translate, not legally binding)
OA06135A (en) Pharmaceutical composition for oral administration.
GB1367608A (en) Oral pharmaceutical dosage form
IL30959A (en) New cyclopeptides,process for their preparation and pharmaceutical compositions containing them
ES361494A1 (en) Procedure for the preparation of medicines with prolonged release of active substance. (Machine-translation by Google Translate, not legally binding)
ES287586A1 (en) A procedure for the preparation of a therapeutic composition (Machine-translation by Google Translate, not legally binding)
ES306376A1 (en) Procedure for the preparation of a pharmaceutical composition. (Machine-translation by Google Translate, not legally binding)
NL158504B (en) PROCESS FOR PREPARING ESTERS OF 17 BETA-HYDROXY- (DELTA) 4-ANDROSTEEN-3-ON, PROCESS FOR PREPARING A DOSED PHARMACEUTICAL PREPARATION, AND FORMULAS SUITABLE FOR MEDICINAL ADMINISTRATION.
IL26600A (en) P-amino-n-(methyl-pyridyl)-benzamides,process for their preparation and pharmaceutical compositions containing them
IL30856A0 (en) New phenanthridine derivatives,processes for their preparation and pharmaceutical compositions containing them